218 related articles for article (PubMed ID: 22820451)
1. Hyaluronic acid-bearing lipoplexes: physico-chemical characterization and in vitro targeting of the CD44 receptor.
Dufaÿ Wojcicki A; Hillaireau H; Nascimento TL; Arpicco S; Taverna M; Ribes S; Bourge M; Nicolas V; Bochot A; Vauthier C; Tsapis N; Fattal E
J Control Release; 2012 Sep; 162(3):545-52. PubMed ID: 22820451
[TBL] [Abstract][Full Text] [Related]
2. Lipoplexes targeting the CD44 hyaluronic acid receptor for efficient transfection of breast cancer cells.
Surace C; Arpicco S; Dufaÿ-Wojcicki A; Marsaud V; Bouclier C; Clay D; Cattel L; Renoir JM; Fattal E
Mol Pharm; 2009; 6(4):1062-73. PubMed ID: 19413341
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells.
Taetz S; Bochot A; Surace C; Arpicco S; Renoir JM; Schaefer UF; Marsaud V; Kerdine-Roemer S; Lehr CM; Fattal E
Oligonucleotides; 2009 Jun; 19(2):103-16. PubMed ID: 19374532
[TBL] [Abstract][Full Text] [Related]
4. Effect of lipid composition on the structure and theoretical phase diagrams of DC-Chol/DOPE-DNA lipoplexes.
Muñoz-Ubeda M; Rodríguez-Pulido A; Nogales A; Martín-Molina A; Aicart E; Junquera E
Biomacromolecules; 2010 Dec; 11(12):3332-40. PubMed ID: 21058732
[TBL] [Abstract][Full Text] [Related]
5. How does the spacer length of cationic gemini lipids influence the lipoplex formation with plasmid DNA? Physicochemical and biochemical characterizations and their relevance in gene therapy.
Muñoz-Úbeda M; Misra SK; Barrán-Berdón AL; Datta S; Aicart-Ramos C; Castro-Hartmann P; Kondaiah P; Junquera E; Bhattacharya S; Aicart E
Biomacromolecules; 2012 Dec; 13(12):3926-37. PubMed ID: 23130552
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronic acid-coated liposomes for active targeting of gemcitabine.
Arpicco S; Lerda C; Dalla Pozza E; Costanzo C; Tsapis N; Stella B; Donadelli M; Dando I; Fattal E; Cattel L; Palmieri M
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):373-80. PubMed ID: 23791684
[TBL] [Abstract][Full Text] [Related]
7. Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells.
Eliaz RE; Szoka FC
Cancer Res; 2001 Mar; 61(6):2592-601. PubMed ID: 11289136
[TBL] [Abstract][Full Text] [Related]
8. Transfection efficiencies of α-tocopherylated cationic gemini lipids with hydroxyethyl bearing headgroups under high serum conditions.
Maiti B; Kamra M; Karande AA; Bhattacharya S
Org Biomol Chem; 2018 Mar; 16(11):1983-1993. PubMed ID: 29498723
[TBL] [Abstract][Full Text] [Related]
9. Novel ortho ester-based, pH-sensitive cationic lipid for gene delivery in vitro and in vivo.
Guo X; Gagne L; Chen H; Szoka FC
J Liposome Res; 2014 Jun; 24(2):90-8. PubMed ID: 24188532
[TBL] [Abstract][Full Text] [Related]
10. Enhanced in vitro and in vivo cationic lipid-mediated gene delivery with a fluorinated glycerophosphoethanolamine helper lipid.
Boussif O; Gaucheron J; Boulanger C; Santaella C; Kolbe HV; Vierling P
J Gene Med; 2001; 3(2):109-14. PubMed ID: 11318109
[TBL] [Abstract][Full Text] [Related]
11. Supramolecular Organization and siRNA Binding of Hyaluronic Acid-Coated Lipoplexes for Targeted Delivery to the CD44 Receptor.
Nascimento TL; Hillaireau H; Noiray M; Bourgaux C; Arpicco S; Pehau-Arnaudet G; Taverna M; Cosco D; Tsapis N; Fattal E
Langmuir; 2015 Oct; 31(41):11186-94. PubMed ID: 26375384
[TBL] [Abstract][Full Text] [Related]
12. Novel cationic liposomes provide highly efficient delivery of DNA and RNA into dendritic cell progenitors and their immature offsets.
Markov OO; Mironova NL; Maslov MA; Petukhov IA; Morozova NG; Vlassov VV; Zenkova MA
J Control Release; 2012 Jun; 160(2):200-10. PubMed ID: 22155599
[TBL] [Abstract][Full Text] [Related]
13. Efficient and safe delivery of siRNA using anionic lipids: Formulation optimization studies.
Kapoor M; Burgess DJ
Int J Pharm; 2012 Aug; 432(1-2):80-90. PubMed ID: 22575754
[TBL] [Abstract][Full Text] [Related]
14. Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery.
Liu Y; Sun J; Cao W; Yang J; Lian H; Li X; Sun Y; Wang Y; Wang S; He Z
Int J Pharm; 2011 Dec; 421(1):160-9. PubMed ID: 21945183
[TBL] [Abstract][Full Text] [Related]
15. Ca(2+)-mediated anionic lipid-plasmid DNA lipoplexes. Electrochemical, structural, and biochemical studies.
Barrán-Berdón AL; Yélamos B; Malfois M; Aicart E; Junquera E
Langmuir; 2014 Oct; 30(39):11704-13. PubMed ID: 25211646
[TBL] [Abstract][Full Text] [Related]
16. Targeting of plasmid DNA-lipoplexes to cells with molecules anchored via a metal chelator lipid.
Herringson TP; Patlolla RR; Altin JG
J Gene Med; 2009 Nov; 11(11):1048-63. PubMed ID: 19757485
[TBL] [Abstract][Full Text] [Related]
17. Low molecular weight hyaluronan shielding of DNA/PEI polyplexes facilitates CD44 receptor mediated uptake in human corneal epithelial cells.
Hornof M; de la Fuente M; Hallikainen M; Tammi RH; Urtti A
J Gene Med; 2008 Jan; 10(1):70-80. PubMed ID: 18044795
[TBL] [Abstract][Full Text] [Related]
18. The analysis of serum effects on structure, size and toxicity of DDAB-DOPE and DC-Chol-DOPE lipoplexes contributes to explain their different transfection efficiency.
Esposito C; Generosi J; Mossa G; Masotti A; Castellano AC
Colloids Surf B Biointerfaces; 2006 Dec; 53(2):187-92. PubMed ID: 17049213
[TBL] [Abstract][Full Text] [Related]
19. Cationic liposome (DC-Chol/DOPE=1:2) and a modified ethanol injection method to prepare liposomes, increased gene expression.
Maitani Y; Igarashi S; Sato M; Hattori Y
Int J Pharm; 2007 Sep; 342(1-2):33-9. PubMed ID: 17566677
[TBL] [Abstract][Full Text] [Related]
20. A physicochemical characterization of the interaction between DC-Chol/DOPE cationic liposomes and DNA.
Rodríguez-Pulido A; Ortega F; Llorca O; Aicart E; Junquera E
J Phys Chem B; 2008 Oct; 112(39):12555-65. PubMed ID: 18729499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]